Flagship Pioneering, LLC
CIK 1400240 · View on SEC EDGAR ↗
- Portfolio value
- $1.5B
- Positions
- 5
- As of
- June 30, 2026
#1,833 of 9,443 by 13F value · top 19.4%
Portfolio value QoQ: +32.8% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 4
- Effective number of positions
- 1.9
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $0
Median holding: 5.0 quarters Tracked Q4 2024–Q2 2026 · 71.4% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 0
- Closed
- 1
On this page
Sector breakdown
Healthcare
31.1%
Other/Unmapped
68.9%
Full portfolio 5 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: 370920100) | $1,057,295,483 | 68.93% | 62,673,117 | $273,881,520 | |||
| MRNA Moderna, Inc. - Common Stock | $324,114,597 | 21.13% | 4,628,225 | $89,000,767 | |||
| SANA Sana Biotechnology, Inc. - Common Stock | $87,256,477 | 5.69% | 25,001,856 | $15,251,131 | |||
| FHTX Foghorn Therapeutics Inc. - Common Stock | $61,849,706 | 4.03% | 12,674,120 | $1,267,412 | |||
| MCRB Seres Therapeutics, Inc. - Common Stock | $3,334,654 | 0.22% | 422,643 | $-414,190 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| OMGAQ | March 31, 2025 | 6,984,856 | $5,207,908 | No longer tracked |